Radiofrequency ablation: Technique and clinical applications

Diagnostic and Interventional Radiology

Volumn 18, Issue 5, 2012, Pages 508-516

  Tatli, Servet ^a   Tapan, Ümit ^b   Morrison, Paul R ^a   Silverman, Stuart G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Percutaneous; Radiofrequency catheter ablation; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT;

BONE TUMOR; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; ELECTRIC RESISTANCE; ELECTRODE; HUMAN; IMAGE ENHANCEMENT; IMPEDANCE; KIDNEY TUMOR; LIVER METASTASIS; LIVER TUMOR; LUNG TUMOR; MEDICAL INSTRUMENTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATIENT SAFETY; POWER SUPPLY; QUALITY OF LIFE; RADIATION ENERGY; RADIOFREQUENCY ABLATION; REVIEW; SOLID TUMOR; SURVIVAL RATE; SURVIVAL TIME; TISSUE INJURY;

ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; FEMALE; HUMANS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASES; NEOPLASMS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84866064607     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: 10.4261/1305-3825.DIR.5168-11.1     Document Type: Review

References (47)

1. Gillams AR. The use of radiofrequency in cancer. Br J Cancer 2005; 92:1825-1829.
2. Gillams A. Tumor ablation: current role in the kidney, lung and bone. Cancer Imaging 2009; 9:68-70.
3. Bilchik AJ, Rose DM, Allegra DP, Bostick PJ, Hsueh E, Morton DL. Radiofrequency ablation: a minimally invasive technique with multiple applications. Cancer J Sci Am 1999; 5:356-361.
4. Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008; 9: 621-628.
5. Dupuy DE, Mayo-Smith WW, Abbott GF, DiPetrillo T. Clinical applications of radiofrequency tumor ablation in the thorax. Radiographics 2002; 22:259-269.
6. Iannitti DA, Dupuy DE, Mayo-Smith WW, Murphy B. Hepatic radiofrequency ablation. Arch Surg 2002; 137:422-426.
7. Li WH. Ma KW, Cheng M, et al. Radiofrequency ablation for hepatocellular carcinoma: a survival analysis of 117 patients. ANZ J Surg 2010; 80:714-721.
8. Zagoria RJ, Pettus JA, Rogers M, Werle DM, Childs D, Leyendecker JR. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology 2011; 77:1393-1397.
9. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005; 185: 64-71.
10. Pennathur A, Luketich JD, Abbas G, et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg 2007; 134:857-864.
11. Hiraki T, Gobara H, Iishi T, et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: Results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg 2007; 134:1306-1312.
12. Hoffmann RT, Jakobs TF, Kubisch CH, et al. Radiofrequency ablation in the treatment of osteoid osteoma-5-year experience. Eur J Radiol 2010; 73:374-379.
13. Rosenthal DI, Hornicek FJ, Torriani M, Gebhardt MC, Mankin HJ. Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology 2003; 229:171-175.
14. Gillams AR, Lees WR. Radiofrequency ablation of colorectal liver metastases. Abdom Imaging 2005; 30:419-426.
15. Huang J, Hernandez-Alejandro R, Croome KP, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases. J Gastrointest Surg 2011; 15:311-320.
16. Song I, Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol 2009; 19:2630-2640.
17. Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. AJR Am J Roentgenol 2008; 190:91-98.
18. Rhim H, Dodd GD 3rd, Chintapalli KN, et al. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 2004; 24:41-52.
19. Meloni MF, Goldberg SN, Moser V, Piazza G, Livraghi T. Colonic perforation and abscess following radiofrequency ablation treatment of hepatoma. Eur J Ultrasound 2002; 15:73-76.
20. Rhim H, Yoon KH, Lee JM, et al. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics 2003; 23: 123-136.
21. Bosch FX, Ribes J, Cléries R, Díaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005; 9:191-211.
22. Venkatesan AM, Gervais DA, Mueller PR. Percutaneous radiofrequency thermal ablation of primary and metastatic hepatic tumors: current concepts and review of the literature. Semin Intervent Radiol 2006; 23: 73-84.
23. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103:1201-1209.
24. Lencioni R, Cioni D, Crocetti L, et al. Earlystage hepatocellular carcinoma in patients with cirrhosis: long-term Results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234:961-967.
25. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214:761-768.
26. Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 2004; 14:2261-2267.
27. Berber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 2005; 23:1358-1364.
28. Stang A, Fischbach R, Teichmann W, Bokemeyer C, Braumann D. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 2009; 45:1748-1756.
29. Elvin A, Skogseid B, Hellman P. Radiofrequency ablation of neuroendocrine liver metastases. Abdom Imaging 2005; 30:427-434.
30. Livraghi T, Goldberg SN, Solbiati L, Meloni F, Ierace T, Gazelle GS. Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 2001; 220:145-149.
31. Rajdev L, Keller SM. Neoadjuvant and adjuvant therapy of non-small cell lung cancer. Surg Oncol 2002; 11:243-253.
32. Licker M, Spiliopoulos A, Frey JG, et al. Risk factors for early mortality and major complications following pneumonectomy for non-small cell carcinoma of the lung. Chest 2002; 121:1890-1897.
33. Crocetti L, Lencioni R. Radiofrequency ablation of pulmonary tumors. Eur J Radiol 2010; 75:23-27.
34. Steinke K, Sewell PE, Dupuy D, et al. Pulmonary radiofrequency ablation: an international study survey. Anticancer Res 2004; 24:339-343.
35. Okuma T, Matsuoka T, Yamamoto A, et al. Frequency and risk factors of various complications after computed tomographyguided radiofrequency ablation of lung tumors. Cardiovasc Intervent Radiol 2008; 31: 122-130.
36. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225-249.
37. Salas N, Ramanathan R, Dummett S, Leveillee RJ. Results of radiofrequency kidney tumor ablation: renal function preservation and oncologic efficacy. World J Urol 2010; 28:583-591.
38. Thanos L, Mylona S, Galani P, et al. Radiofrequency ablation of osseous metastases for the palliation of pain. Skeletal Radiol 2008; 37:189-194.
39. Dupuy DE, Liu D, Hartfeil D, et al. Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer 2010; 116:989-997.
40. Rosenthal DI, Alexander A, Rosenberg AE, Springfield D. Ablation of osteoid osteomas with a percutaneously placed electrode: a new procedure. Radiology 1992; 183: 29-33.
41. Wolf FJ, Dupuy DE, Machan JT, Mayo-Smith WW. Adrenal neoplasms: effectiveness and safety of CT-guided ablation of 23 tumors in 22 patients. Eur J Radiol 2012; 81: 1717-1723.
42. Roman A, Papanna R, Johnson A, et al. Selective reduction in complicated monochorionic pregnancies: radiofrequency ablation vs. bipolar cord coagulation. Ultrasound Obstet Gynecol 2010; 36:37-41.
43. Vossen JA, Buijs M, Kamel IR. Assessment of tumor response on MR imaging after locoregional therapy. Tech Vasc Interv Radiol 2006; 9:125-132.
44. Newatia A, Khatri G, Friedman B, Hines J. Subtraction imaging: applications for nonvascular abdominal MRI. AJR Am J Roentgenol 2007; 188:1018-1025.
45. Schraml C, Schwenzer NF, Clasen S, et al. Navigator respiratory-triggered diffusion-weighted imaging in the follow-up after hepatic radiofrequency ablation-initial results. J Magn Reson Imaging 2009; 29: 1308-1316.
46. Boss A, Martirosian P, Schraml C, et al. Morphological, contrast-enhanced and spin labeling perfusion imaging for monitoring of relapse after RF ablation of renal cell carcinomas. Eur Radiol 2006; 16:1226-1236.
47. Purandare NC, Rangarajan V, Shah SA, et al. Therapeutic response to radiofrequency ablation of neoplastic lesions: FDG PET/CT findings. Radiographics 2011; 31:201-213.